Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.980
-0.015 (-0.75%)
At close: Sep 9, 2025, 4:00 PM
1.981
+0.001 (0.04%)
After-hours: Sep 9, 2025, 6:16 PM EDT
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $111.42 million as of September 9, 2025. Its market cap has increased by 51.03% in one year.
Market Cap
111.42M
Enterprise Value
83.85M
1-Year Change
51.03%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $159.82M to $111.42M, a decrease of -30.28%. That is a compound annual growth rate of -4.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 112.27M | 99.93% |
| Dec 31, 2024 | 56.15M | -27.92% |
| Dec 29, 2023 | 77.91M | -13.02% |
| Dec 30, 2022 | 89.57M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.83% |
| Dec 31, 2020 | 527.17M | 186.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |